This report analyzes the global anemia drugs market by anemia type (iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia, pernicious anemia and others), by route of administration (oral and injectable), by product type (biologics and non-biologics), end user (hospitals and self-administered); it also studies the top manufacturers in the market.
The global anemia drugs market is expected to be around USD 21.4 billion and is projected to reach USD 34.7 billion by the end of forecast period, at a CAGR of 8.4%.
The major players in global anemia drugs market include:
• Amgen Inc.
• GlaxoSmithKline plc
• Bluebird bio
• GlycoMimetics Inc.
• Regen biopharma Inc.
• Bayer AG
• Acceleron Pharma
• Eli Lilly and company
The market revenue and share have been analyzed with respect to the following regions and countries:
Rest of Western Europe
Republic of Korea
Rest of Asia Pacific
The Middle East & Africa
On the basis of anemia type, the global anemia drugs market has been categorized into the following segments:
• Iron Deficiency Anemia
• Sickle Cell Anemia
• Aplastic Anemia
• Hemolytic Anemia
• Pernicious Anemia
On the basis of route of administration, the global anemia drugs market has been categorized into the following segments:
On the basis of product type, the global anemia drugs market has been categorized into the following segments:
On the basis of end-user, the global anemia drugs market has been categorized into the following segments:
Analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data.
Table of Content: Key Points
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Anemia Drugs Market, By Anemia Type
6 Global Anemia Drugs Market, By Route Of Administration
7 Global Anemia Drugs Market, By Product Type
8 Global Anemia Drugs Market, By End User
Get in touch:
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349